Trials / Unknown
UnknownNCT04354818
Coronavirus (COVID-19) Outcomes Registries in Immunocompromised Individuals Australia (CORIA)
Coronavirus Outcomes Registries in Immunocompromised Individuals Australia (CORIA): a Multisite Registry and Optional Biorepository in People With COVID-19 and Selected Conditions Affecting Immune Function
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 27 (actual)
- Sponsor
- Kirby Institute · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
CORIA is an observational cohort study of immunosuppressed populations who test positive for COVID-19. This includes people living with HIV, cancer, acquired immunodeficiency associated with other immunosuppressive therapy, primary immunodeficiency and recipients of a solid organ transplant. Participants will have routine clinical data collected with optional baseline collection and storage of a blood sample for storage . The study will be conducted in up to 30 sites within Australia.
Conditions
Timeline
- Start date
- 2020-05-11
- Primary completion
- 2022-04-27
- Completion
- 2022-04-27
- First posted
- 2020-04-21
- Last updated
- 2021-09-01
Locations
11 sites across 1 country: Australia
Source: ClinicalTrials.gov record NCT04354818. Inclusion in this directory is not an endorsement.